A detailed history of Armstrong Henry H Associates Inc transactions in Care Dx, Inc. stock. As of the latest transaction made, Armstrong Henry H Associates Inc holds 16,036 shares of CDNA stock, worth $372,195. This represents 0.05% of its overall portfolio holdings.

Number of Shares
16,036
Previous 16,036 -0.0%
Holding current value
$372,195
Previous $249,000 100.8%
% of portfolio
0.05%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 22, 2020

BUY
$18.95 - $35.43 $303,882 - $568,155
16,036 New
16,036 $568,000
Q1 2020

May 05, 2020

SELL
$13.94 - $28.25 $223,541 - $453,017
-16,036 Closed
0 $0
Q1 2019

Apr 16, 2019

BUY
$22.09 - $39.21 $354,235 - $628,771
16,036 New
16,036 $505,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.24B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Armstrong Henry H Associates Inc Portfolio

Follow Armstrong Henry H Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armstrong Henry H Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Armstrong Henry H Associates Inc with notifications on news.